Analysed VIVOSIM LABS INC (VIVS:NASDAQ) News Sources
VivoSim Appoints Arumugham (Ragoo) Raghunathan as Vice President of Global Sales
03-03-2026
yahoo.com
VivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCs
24-03-2026
yahoo.com
VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing
28-04-2026
yahoo.com
VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting
29-06-2026
yahoo.com
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
15-07-2026
yahoo.com
VivoSim Receives $5 Million Milestone Payment From Eli Lilly and Forecasts 500%+ FY2027 Revenue Growth
15-07-2026
advfn.com
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Institutional Investor
16-07-2026
yahoo.com
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
21-07-2026
yahoo.com
What is the current price of VIVOSIM LABS INC (VIVS:NASDAQ)?
The current price of VIVOSIM LABS INC (VIVS:NASDAQ) is $0.3446.
VIVOSIM LABS INC (VIVS:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIVOSIM LABS INC (VIVS:NASDAQ) since the previous trading day is $-0.0414.
VIVOSIM LABS INC (VIVS:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIVOSIM LABS INC (VIVS:NASDAQ) since the previous trading day is -10.7254%.
What is the most recent average sentiment score for VIVOSIM LABS INC (VIVS:NASDAQ)?
The most recent average sentiment score for VIVOSIM LABS INC (VIVS:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for VIVOSIM LABS INC (VIVS:NASDAQ)?
The most recent sentiment for VIVOSIM LABS INC (VIVS:NASDAQ) is .
SEC-8K** Filing Available For VIVOSIM LABS INC (VIVS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.